Filing Details
- Accession Number:
- 0001127602-10-030128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-09 18:39:17
- Reporting Period:
- 2010-12-08
- Filing Date:
- 2010-12-09
- Accepted Time:
- 2010-12-09 18:39:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376155 | James Thomas Flanagan | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Sr Vp & Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-08 | 750 | $53.37 | 41,826 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported is an average price. The prices ranged from $53.00 to $53.55 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,700 RSUs which vest in two equal annual installments of 2,850 each commencing 4/29/2011; 4,275 RSUs which vest in three equal annual installments of 1,425 each commencing 4/28/2011; and 5,800 RSUs which vest in four equal annual installments of 1,450 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
Billionaire Hedge Funds
